Pulmonary mycobacterial infections affect approximately one third of the world's population and claim millions of lives annually. Infectious organisms that are inhaled into the airspaces encounter alveolar macrophages in the context of immune proteins in the alveolar lining fluid. Specifically, surfactant protein A (SP-A), a lung- specific collectin, orchestrates macrophage activation, phagocytosis and killing of mycobacteria via a 210 kDa (SP-8210) receptor. The long term objective of this application is to elucidate the mechanisms by which SP-A and its receptor direct alveolar macrophage host defense functions in the lung fn vivo. This proposal is based on these new findings: 1) the SP-A receptor is a heterooligomer of 210 kDa (SP-8210) and 240 kDa (SP-8240) cell- surface, and 78 kDa (SP-R78) intracellular proteins. Both SP-8210 and SP-R78 have been sequenced by mass spectrometry.2) The composition of the SP-A receptor heterooligomer may vary based on the state of macrophage differentiation. The central hypothesis of this proposal is that the interaction of SP-A with its receptor coordinates macrophage activation and mycobacterial clearance via distinct SP-A receptor- directed mechanisms. To test this hypothesis we will study SP-A receptor structure and function in the context of mycobacterial infection.
The Specific Aims are: 1) reconstitute a functional SP-A receptor in COS .cells and use a panel of recombinant wild type and mutant SP-A proteins to determine mechanisms of SP-A-binding and function in the phagocytosis of mycobacteria, 2) determine the role of the intracellular SP-R78 in the activation of an SP-A-specific pathway for intracellular targeting of mycobacteria, and 3) study the relative expression of the SP- A receptor components during macrophage differentiation to understand how the structure of the SP-A receptor directs SP-A-mediated mycobacterial clearance and activation of macrophages. To facilitate these studies we will utilize immature alveolar macrophages that we have isolated, and Mycobacterium bovis BCG and Mycobacterium tuberculosis Ra reporter strains that express green fluorescent protein.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
1R01HL068127-01
Application #
6365590
Study Section
Lung Biology and Pathology Study Section (LBPA)
Program Officer
Musson, Robert
Project Start
2001-07-01
Project End
2005-05-31
Budget Start
2001-07-01
Budget End
2002-05-31
Support Year
1
Fiscal Year
2001
Total Cost
$220,793
Indirect Cost
Name
University of Texas Health Center at Tyler
Department
Biochemistry
Type
Other Domestic Higher Education
DUNS #
City
Tyler
State
TX
Country
United States
Zip Code
75708
Minutti, Carlos M; Jackson-Jones, Lucy H; García-Fojeda, Belén et al. (2017) Local amplifiers of IL-4R?-mediated macrophage activation promote repair in lung and liver. Science 356:1076-1080
Yang, Linlin; Carrillo, Marykate; Wu, Yuchieh M et al. (2015) SP-R210 (Myo18A) Isoforms as Intrinsic Modulators of Macrophage Priming and Activation. PLoS One 10:e0126576
Sever-Chroneos, Zvjezdana; Krupa, Agnieszka; Davis, Jeremy et al. (2011) Surfactant protein A (SP-A)-mediated clearance of Staphylococcus aureus involves binding of SP-A to the staphylococcal adhesin eap and the macrophage receptors SP-A receptor 210 and scavenger receptor class A. J Biol Chem 286:4854-70
Sever-Chroneos, Zvjezdana; Tvinnereim, Amy; Hunter, Robert L et al. (2011) Prolonged survival of scavenger receptor class A-deficient mice from pulmonary Mycobacterium tuberculosis infection. Tuberculosis (Edinb) 91 Suppl 1:S69-74
Sever-Chroneos, Zvjezdana; Murthy, Aditi; Davis, Jeremy et al. (2011) GM-CSF modulates pulmonary resistance to influenza A infection. Antiviral Res 92:319-28
Chroneos, Zissis C; Sever-Chroneos, Zvjezdana; Shepherd, Virginia L (2010) Pulmonary surfactant: an immunological perspective. Cell Physiol Biochem 25:13-26
Samten, Buka; Townsend, James C; Sever-Chroneos, Zvjezdana et al. (2008) An antibody against the surfactant protein A (SP-A)-binding domain of the SP-A receptor inhibits T cell-mediated immune responses to Mycobacterium tuberculosis. J Leukoc Biol 84:115-23
Szeliga, Jacek; Daniel, D Sundarsingh; Yang, Ching-Hui et al. (2008) Granulocyte-macrophage colony stimulating factor-mediated innate responses in tuberculosis. Tuberculosis (Edinb) 88:7-20
Yang, Ching-Hui; Szeliga, Jacek; Jordan, Jeremy et al. (2005) Identification of the surfactant protein A receptor 210 as the unconventional myosin 18A. J Biol Chem 280:34447-57
Szeliga, Jacek; Jordan, Jeremy; Yang, Ching-Hui et al. (2005) Bacterial expression of recombinant MyoXVIIIA domains. Anal Biochem 346:179-81